GlaxoSmithKline Pharmaceuticals Limited
NSE: GLAXO | Information Technology
Market Fundamentals
Stock Intelligence & News
GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |SUBJECT: Trading Window
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |SUBJECT: Trading Window-XBRL
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Action(s) taken or orders passed |SUBJECT: Action(s) taken or orders passed
Read Full Analysis →AI-Powered Alerts for Your Portfolio
Alerfo's AI classifies every news event by type, severity, and market impact — then instantly notifies you via Email & WhatsApp only for the stocks you track.
Nuvalent shares surge 39% to record high as GSK agrees to $10.6 billion acquisition deal
Nuvalent's shares surged 39% to $123 after GlaxoSmithKline agreed to acquire the cancer drug developer for $10.6 billion, enhancing its oncology portfolio. 
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding 'Letter for weblink for Annual Report '. |SUBJECT: Updates
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
BRSR Report |SUBJECT: General Updates
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on Jun 30, 2026 |SUBJECT: Shareholders meeting
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |SUBJECT: Copy of Newspaper Publication
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP |SUBJECT: Resignation of Director/KMP/SMP
Read Full Analysis →GlaxoSmithKline Pharmaceuticals Limited
GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/KMP/SMP/Auditor/RTA |SUBJECT: Change in Directors/KMP/SMP/Auditor/RTA
Read Full Analysis →Get instant alerts when GLAXO breaks news
Join investors who track GlaxoSmithKline Pharmaceuticals Limited on Alerfo — free plan available.
Set Free Alert →Frequently Asked Questions
What is the current trend for GLAXO?
GLAXO is currently showing a volatility profile consistent with its sector peers, with sentiment being actively monitored by Alerfo news scanners.
How can I set alerts for GlaxoSmithKline Pharmaceuticals Limited?
You can set real-time price and news alerts by registering on the Alerfo platform and adding GLAXO to your custom watchlist.